Asceneuron will develop novel therapeutics for Alzheimer’s disease and tauopathies to become a leader for neurodegeneration drug discovery
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free